Diamonds and Dogs

9/27/24

Bristol Myers (BMY) jumps on FDA approval for their schizophrenia drug. Bristol rose 1.5% today to a six month high as their new drug to treat schizophrenia works differently than the drugs used by many Americans today to treat schizophrenia. Schizophrenia affects nearly 24 million people worldwide, including 2.8 million people in the US.

Nvidia (NVDA) reverses course, falling 2% after the Chinese government tells domestic companies to not buy Nvidia AI chips and instead to focus sales on domestic AI chips. Chinese regulators have been discouraging companies from purchasing Nvidia's H20 chips for a while, but the new policy isn't an outright ban on Chinese companies buying Nvidia chips but rather guidance as Chinese regulators. Stay tune.

 

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.